BAYZF News and Press, Bayer AG Registered Shares

2026-03-11 09:47:27 ET Regeneron Pharmaceuticals, Inc. ( REGN ) is a well-established biotech company based in Tarrytown, NY, that has had a phenomenal journey since its founding in 1988, but most clearly – for shareholders – since it reached an inflection point in 201...

2026-03-04 12:39:52 ET More on Bayer Bayer Aktiengesellschaft 2025 Q4 - Results - Earnings Call Presentation Bayer Aktiengesellschaft (BAYRY) Discusses Roundup Class Settlement Agreement and Implications for U.S. Glyphosate Litigation Transcript Bayer Aktiengesellsch...

2026-03-04 12:32:18 ET Bayer Aktiengesellschaft (BAYRY) Q4 2025 Earnings Call March 4, 2026 4:00 AM EST... Read the full article on Seeking Alpha For further details see: Bayer Aktiengesellschaft (BAYRY) Q4 2025 Earnings Call Transcript

2026-03-04 10:51:59 ET More on Bayer Bayer Aktiengesellschaft 2025 Q4 - Results - Earnings Call Presentation Bayer Aktiengesellschaft (BAYRY) Discusses Roundup Class Settlement Agreement and Implications for U.S. Glyphosate Litigation Transcript Bayer Aktiengesellsch...

Clearance reinforces Bayer’s continued commitment to dependable, integrated radiology solutions Expanded Tesla compatibility captures low- to high-end field magnetic resonance (MR) systems, now supporting up to and including 7T Imaging Scanner Interface 2 synchroniz...

2026-03-04 03:23:42 ET More on Bayer Bayer Aktiengesellschaft (BAYRY) Discusses Roundup Class Settlement Agreement and Implications for U.S. Glyphosate Litigation Transcript Bayer Aktiengesellschaft (BAYRY) Discusses OCEANIC-STROKE Phase III Results and Asundexian in Seconda...

2026-02-27 14:53:57 ET More on Bayer Bayer Aktiengesellschaft (BAYRY) Discusses Roundup Class Settlement Agreement and Implications for U.S. Glyphosate Litigation Transcript Bayer Aktiengesellschaft (BAYRY) Discusses OCEANIC-STROKE Phase III Results and Asundexian in Seconda...

225 Ac-PSMA-Trillium (BAY 3563254) is an investigational targeted alpha therapy (TAT) being developed for patients with advanced metastatic castration-resistant prostate cancer (mCRPC) Data from PAnTHa, the global Phase I first-in-human, dose-escalation study were presented during the 2026 ...

2026-02-26 14:36:15 ET More on Bayer Bayer Aktiengesellschaft (BAYRY) Discusses Roundup Class Settlement Agreement and Implications for U.S. Glyphosate Litigation Transcript Bayer Aktiengesellschaft (BAYRY) Discusses OCEANIC-STROKE Phase III Results and Asundexian in Seconda...

Final results for the key secondary endpoint of overall survival (OS) from the PEACE-3 trial will be presented by the European Organization for Research and Treatment of Cancer (EORTC) coalition as an oral abstract at ASCO GU 2026. XOFIGO ® (radium-223 dichloride) in combination with...